Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

作者: Rosita Vakili , Faezeh Sabet , Sanaz Aahmadi , Reza Boostani , Houshang Rafatpanah

DOI: 10.22038/IJBMS.2013.745

关键词:

摘要: Human T-cell lymphotropic virus type I (HTLV-I) was the first human retrovirus discovered (1), and it has been estimated that 10-20 million people worldwide are infected with HTLV-I (2). This is endemic in several regions of world, such as southwestern Japan, Caribbean basin, Central Africa, South America, Melanesian Islands, Middle East (3, 4). The prevalence infection Iran (Mashhad) to be 2-3% entire population, 0.7% among blood donors (5). Most HTLV-I-infected individuals remain asymptomatic carriers (6). Whereas, small percentage develop neoplastic disease adult leukemia (ATL), inflammatory condition HTLV-I- associated myelopathy/tropical spastic paraparesis (HAM/TSP) (7). Only 5% HAM/TSP (8). HAM/TSP results demyelination spinal cord clinical manifestations this include progressive muscle weakness hyperreflexia lower limbs, sensory disturbance, urinary incontinence, impotence (9-11). These symptoms generally slowly progressive, while patients at older ages onset show faster progression. Women affected more frequently than men (12, 13). The precise pathophysiology not yet clear but, previous studies suggested both subgroups, host genetic immunological factors may development HAM/TSP, particularly cytokine gene polymorphisms (14, 15). Proviral load a major determinant outcome for chronic infections HIV-1 2, hepatitis B virus, C virus. Also recent have important role proviral T-lymphotropic virus-I (16). In significantly higher loads observed compared carriers, suggesting active viral replication plays key disease. A study shown high level Tax expression low CD8+ anti-viral efficiency correlated (PVL) (17). In risk between Iranian Japanese were compared, found median two-fold greater healthy (HCs), whereas 13-fold HCs. In addition, HCs significant differences two populations reflect leukocyte antigen (HLA) genotype populations. genome DNA samples extracted from whole but peripheral mononuclear cells (PBMCs). probably underestimated comparison ones (18). aim evaluate manifestation compare other parts world.

参考文章(30)
Marco A Lima, Ramza C Harab, Doris Schor, Maria J Andrada-Serpa, Abelardo QC Araújo, Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Journal of NeuroVirology. ,vol. 13, pp. 468- 473 ,(2007) , 10.1080/13550280701510096
Shelene K.W. Poetker, Aurelia F. Porto, Silvana P. Giozza, Andre L. Muniz, Marina F. Caskey, Edgar M. Carvalho, Marshall J. Glesby, Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. Journal of Clinical Virology. ,vol. 51, pp. 54- 58 ,(2011) , 10.1016/J.JCV.2011.02.004
Masako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, Akihiko Okayama, Kaoru Uchimaru, Ki-Ryang Koh, Masao Ogata, Hiroshi Kikuchi, Yasuko Sagara, Kimiharu Uozumi, Manabu Mochizuki, Kunihiro Tsukasaki, Yoshio Saburi, Masaomi Yamamura, Junji Tanaka, Yukiyoshi Moriuchi, Shigeo Hino, Shimeru Kamihira, Kazunari Yamaguchi, , Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. ,vol. 116, pp. 1211- 1219 ,(2010) , 10.1182/BLOOD-2009-12-257410
Mahmood Naderi, Mahdi Paryan, Kayhan Azadmanesh, Houshang Rafatpanah, Houri Rezvan, Siamak Mirab Samiee, Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood Journal of Clinical Virology. ,vol. 53, pp. 302- 307 ,(2012) , 10.1016/J.JCV.2011.12.033
Houshang Rafatpanah, Abdolrahim Rezaee, Mohammad Mehdi Etemadi, Reza Farid Hosseini, Bita Khorram, Leila Afsahr, Graham Taylor, Naghmeh Mokhber, Mahmoud Mahmoudi, Mohammad Reza Abbaszadegan, Mohsen Foroghipor, Peyman Hashemi, Amin Amiri, Mohsen Tehrani, Amir Azarpazhooh, Mahmoud Reza Azarpazhooh, The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran Journal of Neuroimmunology. ,vol. 250, pp. 87- 93 ,(2012) , 10.1016/J.JNEUROIM.2012.05.004
Mineki Saito, Nobutaka Eiraku, Koichiro Usuku, Yasuyuki Nobuhara, Wataru Matsumoto, Daisuke Kodama, Amir H. Sabouri, Shuji Izumo, Kimiyoshi Arimura, Mitsuhiro Osame, ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals Journal of the Neurological Sciences. ,vol. 232, pp. 29- 35 ,(2005) , 10.1016/J.JNS.2005.01.005
Fernando A Proietti, Anna Bárbara F Carneiro-Proietti, Bernadette C Catalan-Soares, Edward L Murphy, Global epidemiology of HTLV-I infection and associated diseases. Oncogene. ,vol. 24, pp. 6058- 6068 ,(2005) , 10.1038/SJ.ONC.1208968
J. R. Orland, J. Engstrom, J. Fridey, R. A. Sacher, J. W. Smith, C. Nass, G. Garratty, B. Newman, D. Smith, B. Wang, K. Loughlin, E. L. Murphy, Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. ,vol. 61, pp. 1588- 1594 ,(2003) , 10.1212/01.WNL.0000096011.92542.DA